Publication Date
| In 2025 | 0 |
| Since 2024 | 0 |
| Since 2021 (last 5 years) | 0 |
| Since 2016 (last 10 years) | 1 |
Descriptor
| Age Differences | 1 |
| Autism | 1 |
| Developmental Disabilities | 1 |
| Diabetes | 1 |
| Drug Therapy | 1 |
| Drug Use | 1 |
| Gender Differences | 1 |
| Hypertension | 1 |
| Intellectual Disability | 1 |
| Metabolism | 1 |
| Nursing Homes | 1 |
| More ▼ | |
Source
| Journal of Autism and… | 1 |
Author
| Bakian, Amanda V. | 1 |
| Bilder, Deborah A. | 1 |
| Carbone, Paul S. | 1 |
| Damron, Mackenzie | 1 |
| Jones, Kyle B. | 1 |
| Ruiz, Lisa M. | 1 |
| Weedon, Dean | 1 |
Publication Type
| Journal Articles | 1 |
| Reports - Research | 1 |
Education Level
Audience
Location
Laws, Policies, & Programs
Assessments and Surveys
What Works Clearinghouse Rating
Peer reviewed
Direct linkRuiz, Lisa M.; Damron, Mackenzie; Jones, Kyle B.; Weedon, Dean; Carbone, Paul S.; Bakian, Amanda V.; Bilder, Deborah A. – Journal of Autism and Developmental Disorders, 2016
This study describes antipsychotic use and metabolic monitoring rates among individuals with developmental disabilities enrolled in a subspecialty medical home (N = 826). Four hundred ninety-nine participants (60.4%) were taking antipsychotics, which was associated with male gender (p = 0.01), intellectual disability with and without autism…
Descriptors: Developmental Disabilities, Drug Use, Drug Therapy, Metabolism
